Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study.
Vermeiren MR, Somsen J, Luurtsema G, Reesink FE, Verwey NA, Hempenius L, Tolboom N, Biessels GJ, Biesbroek JM, Vernooij MW, Veldhuijzen van Zanten SEM, Seelaar H, Coomans EM, Teunissen CE, Lemstra AW, van Harten AC, Visser LNC, van der Flier WM, van de Giessen E, Ossenkoppele R. Vermeiren MR, et al. Among authors: veldhuijzen van zanten sem. Alzheimers Res Ther. 2024 Oct 19;16(1):230. doi: 10.1186/s13195-024-01588-4. Alzheimers Res Ther. 2024. PMID: 39427210 Free PMC article.
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors.
Metselaar DS, Meel MH, Goulding JR, du Chatinier A, Rigamonti L, Waranecki P, Geisemeyer N, de Gooijer MC, Breur M, Koster J, Veldhuijzen van Zanten SEM, Bugiani M, Franke NE, Reddy A, Wesseling P, Kaspers GJL, Hulleman E. Metselaar DS, et al. Among authors: veldhuijzen van zanten sem. Cell Rep Med. 2024 Sep 17;5(9):101700. doi: 10.1016/j.xcrm.2024.101700. Epub 2024 Aug 28. Cell Rep Med. 2024. PMID: 39208799 Free PMC article.
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile.
Nussbaumer G, Benesch M, Grabovska Y, Mackay A, Castel D, Grill J, Alonso MM, Antonelli M, Bailey S, Baugh JN, Biassoni V, Blattner-Johnson M, Broniscer A, Carai A, Colafati GS, Colditz N, Corbacioglu S, Crampsie S, Entz-Werle N, Eyrich M, Friker LL, Frühwald MC, Garrè ML, Gerber NU, Giangaspero F, Gil-da-Costa MJ, Graf N, Hargrave D, Hauser P, Herrlinger U, Hoffmann M, Hulleman E, Izquierdo E, Jacobs S, Karremann M, Kattamis A, Kebudi R, Kortmann RD, Kwiecien R, Massimino M, Mastronuzzi A, Miele E, Morana G, Noack CM, Pentikainen V, Perwein T, Pfister SM, Pietsch T, Roka K, Rossi S, Rutkowski S, Schiavello E, Seidel C, Štěrba J, Sturm D, Sumerauer D, Tacke A, Temelso S, Valentini C, van Vuurden D, Varlet P, Veldhuijzen van Zanten SEM, Vinci M, von Bueren AO, Warmuth-Metz M, Wesseling P, Wiese M, Wolff JEA, Zamecnik J, Morales La Madrid A, Bison B, Gielen GH, Jones DTW, Jones C, Kramm CM. Nussbaumer G, et al. Among authors: veldhuijzen van zanten sem. Neuro Oncol. 2024 Sep 5;26(9):1723-1737. doi: 10.1093/neuonc/noae080. Neuro Oncol. 2024. PMID: 38717379 Free PMC article.
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.
Pruis IJ, van Doormaal PJ, Balvers RK, van den Bent MJ, Harteveld AA, de Jong LC, Konijnenberg MW, Segbers M, Valkema R, Verburg FA, Smits M, Veldhuijzen van Zanten SEM. Pruis IJ, et al. Among authors: veldhuijzen van zanten sem. EBioMedicine. 2024 Apr;102:105068. doi: 10.1016/j.ebiom.2024.105068. Epub 2024 Mar 22. EBioMedicine. 2024. PMID: 38518652 Free PMC article. Clinical Trial.
FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances.
Veldhuijzen van Zanten SEM, Pieterman KJ, Wijnhoven BPL, Pruis IJ, Groot Koerkamp B, van Driel LMJW, Verburg FA, Thomeer MGJ. Veldhuijzen van Zanten SEM, et al. Diagnostics (Basel). 2022 Aug 12;12(8):1958. doi: 10.3390/diagnostics12081958. Diagnostics (Basel). 2022. PMID: 36010308 Free PMC article. Review.
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.
Gielen GH, Baugh JN, van Vuurden DG, Veldhuijzen van Zanten SEM, Hargrave D, Massimino M, Biassoni V, Morales la Madrid A, Karremann M, Wiese M, Thomale U, Janssens GO, von Bueren AO, Perwein T, Nussbaumer G, Hoving EW, Niehusmann P, Gessi M, Kwiecien R, Bailey S, Pietsch T, Andreiuolo F, Kramm CM. Gielen GH, et al. Among authors: veldhuijzen van zanten sem. Neurooncol Adv. 2022 May 20;4(1):vdac077. doi: 10.1093/noajnl/vdac077. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35733513 Free PMC article.
Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters.
Pruis IJ, Koene SR, van der Voort SR, Incekara F, Vincent AJPE, van den Bent MJ, Lycklama À Nijeholt GJ, Nandoe Tewarie RDS, Veldhuijzen van Zanten SEM, Smits M. Pruis IJ, et al. Among authors: veldhuijzen van zanten sem. Neurooncol Adv. 2022 Feb 21;4(1):vdac023. doi: 10.1093/noajnl/vdac023. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35300151 Free PMC article.
34 results